MX9101540A - Polimeros de proantocianidina que tienen actividad antiviral y metodos para obtener los mismos - Google Patents

Polimeros de proantocianidina que tienen actividad antiviral y metodos para obtener los mismos

Info

Publication number
MX9101540A
MX9101540A MX9101540A MX9101540A MX9101540A MX 9101540 A MX9101540 A MX 9101540A MX 9101540 A MX9101540 A MX 9101540A MX 9101540 A MX9101540 A MX 9101540A MX 9101540 A MX9101540 A MX 9101540A
Authority
MX
Mexico
Prior art keywords
polymers
antiviral activity
methods
proantocyanidine
proanthocyanidin polymers
Prior art date
Application number
MX9101540A
Other languages
English (en)
Inventor
Michael S Tempesta
Original Assignee
Shaman Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaman Pharmaceuticals Inc filed Critical Shaman Pharmaceuticals Inc
Publication of MX9101540A publication Critical patent/MX9101540A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
MX9101540A 1990-10-12 1991-10-11 Polimeros de proantocianidina que tienen actividad antiviral y metodos para obtener los mismos MX9101540A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59689390A 1990-10-12 1990-10-12
US07/737,077 US5211944A (en) 1990-10-12 1991-07-29 Proanthocyanidin polymers having antiviral activity and methods of obtaining same

Publications (1)

Publication Number Publication Date
MX9101540A true MX9101540A (es) 1992-06-05

Family

ID=27082674

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9101540A MX9101540A (es) 1990-10-12 1991-10-11 Polimeros de proantocianidina que tienen actividad antiviral y metodos para obtener los mismos

Country Status (12)

Country Link
US (2) US5211944A (es)
EP (1) EP0553253B1 (es)
JP (1) JP3448052B2 (es)
KR (1) KR100207949B1 (es)
AT (1) ATE194288T1 (es)
AU (1) AU660631B2 (es)
CA (1) CA2093825C (es)
DE (1) DE69132289D1 (es)
MX (1) MX9101540A (es)
NZ (1) NZ240200A (es)
SG (1) SG52707A1 (es)
WO (1) WO1992006695A1 (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981163A (en) * 1990-05-15 1999-11-09 New York Blood Center, Inc. Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions
EP0633887B1 (en) * 1992-03-31 1999-05-19 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services Calanolide antiviral compounds, compositions and uses thereof
US5591770A (en) * 1992-03-31 1997-01-07 The United States Of America As Represented By The Department Of Health And Human Services Calanolide and related antiretroviral compounds, compositions, and uses thereof
US6774141B1 (en) 1992-03-31 2004-08-10 The United States Of America As Represented By The Secretary Of Health And Human Services Calanolide and related antiviral compounds, compositions, and uses thereof
US5646178A (en) * 1992-10-09 1997-07-08 Jlb, Inc. Cranberry extract and biologically active compounds derived therefrom
US5650432A (en) * 1995-03-24 1997-07-22 Jlb, Inc. Method of treating or preventing non-viral microbial infection
KR100258377B1 (ko) * 1993-05-28 2000-06-01 존 더블유. 아담슨 엠. 디. 생물학적 조성물의 살균 방법 및 이에 의해 생성된 생성물
US5892060A (en) * 1994-08-03 1999-04-06 Sarawak Medichem Pharmaceuticals, Inc. Method for the preparation of (+)-calanolide a and analogues thereof
US5977385A (en) * 1994-08-03 1999-11-02 Sarawak Medichem Pharmaceuticals Method for the preparation of (+)-calanolide A and analogues thereof
US6277879B1 (en) 1994-08-03 2001-08-21 Sarawak Medichem Pharmaceuticals, Inc. Calanolide analogues and methods of their use
US6043271A (en) * 1994-08-03 2000-03-28 Sarawak Medichem Pharmaceuticals, Inc. Method for the preparation of (±)-calanolide A and intermediates thereof
US5554645A (en) * 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
ATE430477T1 (de) 1996-10-16 2009-05-15 Napo Pharmaceuticals Inc Enteral-formulierungen von proanthocyanidzusammensetzungen gegen diarrhöe
AU775330B2 (en) * 1996-10-16 2004-07-29 Napo Pharmaceuticals Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
JP3213557B2 (ja) * 1996-11-18 2001-10-02 三井農林株式会社 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
US6197808B1 (en) * 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
AU744527B2 (en) 1997-09-09 2002-02-28 Rutgers, The State University Of New Jersey Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with P-type fimbriae to surfaces
US6060235A (en) 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
WO2000064903A2 (en) 1999-04-26 2000-11-02 Sarawak Medichem Pharmaceuticals, Inc. Methods for preparing antiviral calanolide compounds
WO2001003681A2 (en) 1999-07-08 2001-01-18 Prendergast Patrick T Use of flavones, coumarins and related compounds to treat infections
WO2001011988A2 (en) * 1999-08-13 2001-02-22 Dry Creek Nutrition, Inc. Novel polyphenolic polymeric compositions, method of their isolation, and a method of altering and improving taste characteristics of edible consumables
US6210681B1 (en) * 1999-09-07 2001-04-03 Jlb, Inc. Plant proanthocyanidin extracts
WO2001028370A1 (fr) * 1999-10-20 2001-04-26 Daicel Chemical Industries, Ltd. Ingredient pour cigarette et procede de fabrication
US6391330B1 (en) 2000-05-11 2002-05-21 Michael A. Ross Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
US6960360B2 (en) * 2000-08-31 2005-11-01 Phenolics, Llc Efficient method for producing compositions enriched in total phenols
DE60120209T2 (de) * 2000-08-31 2007-03-29 Phenolics Llc Effiziente methode zur herstellung von zusammensetzungen, die mit anthocyaninen angereichert sind
US7306815B2 (en) * 2000-08-31 2007-12-11 Phenolics, Llc Compositions enriched in phenolic compounds and methods for producing the same
EP1213025A1 (de) * 2000-12-06 2002-06-12 Laboratoires Serobiologiques(Societe Anonyme) Kosmetische und/oder dermopharmazeutische Zubereitungen enthaltend Extrakte aus den Blättern der Pflanze Argania spinosa
US20050220753A1 (en) * 2002-03-22 2005-10-06 Beijing Jiankai Technology Co., Ltd Hydrophilic polymers-flavoids conjugates and pharmaceutical compositions comprising them
WO2003092654A1 (en) 2002-05-02 2003-11-13 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US7208183B2 (en) 2002-10-05 2007-04-24 Bobrowski Paul J Methods and preparations of the latex from the croton species
US20040071793A1 (en) * 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
AU2004220541B2 (en) * 2003-03-12 2009-03-26 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
FR2852842A1 (fr) * 2003-03-31 2004-10-01 Silab Sa Procede de preparation d'un principe actif a partir d'exsudat de resine des fruits de daemonorops draco, compositions l'incluant et utilisations
US20050074510A1 (en) * 2003-10-04 2005-04-07 Bobrowski Paul J. Topical preparations for use in treatment of anorectal disease
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
JPWO2005089780A1 (ja) * 2004-03-18 2008-01-31 有限会社梅田事務所 抗エイズウイルス性組成物及びウイルス感染細胞の選択的不活化方法
JP2005314316A (ja) * 2004-04-30 2005-11-10 Kikkoman Corp 抗ｓａｒｓコロナウイルス剤
US20070065486A1 (en) * 2004-05-21 2007-03-22 Migco Limited Migraine remedy
ES2245610B1 (es) * 2004-06-23 2007-03-16 Investigacion Y Nutricion, S.L. Producto de origen vegetal y su procedimiento de obtencion.
US20060073220A1 (en) * 2004-07-08 2006-04-06 Daugherty F J Cinnamon extract enriched for polyphenols and methods of preparing same
US20060204600A1 (en) * 2005-03-11 2006-09-14 Paul Konz Dragon's blood anti-viral materials and methods
US20090076132A1 (en) * 2005-03-11 2009-03-19 Gary Pekoe Antiviral compositions and methods of treatment
US20080166426A1 (en) * 2005-03-11 2008-07-10 Gary Pekoe Anitbacterial compositions and methods of treatment
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
CA2650022C (en) * 2006-05-01 2017-05-16 Barry Quart Method for treatment of constipation-predominant irritable bowel syndrome
EP2061327B1 (en) 2006-05-01 2016-10-05 Napo Pharmaceuticals, Inc. Compositions for treating or preventing inflammatory bowel disease
JP4892690B2 (ja) 2008-09-03 2012-03-07 財団法人宮崎県産業支援財団 Ｃ型肝炎ウイルス産生抑制剤
US8629121B2 (en) * 2009-01-27 2014-01-14 World Force Technologies, Llc High molecular weight polysaccharide that binds and inhibits virus
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
JP5343016B2 (ja) * 2010-01-22 2013-11-13 株式会社ロッテ 抗インフルエンザウイルス剤及びこれを吸着、含浸、添加させてなるインフルエンザ感染抑制用品
US20130164338A1 (en) 2010-08-30 2013-06-27 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
CN105640925B (zh) 2010-08-30 2019-08-16 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
CA2812417C (en) 2010-09-29 2019-10-22 Pulmatrix, Inc. Cationic dry powders
RU2640921C2 (ru) 2010-09-29 2018-01-12 Пулмэтрикс, Инк. Катионы одновалентных металлов сухих порошков для ингаляций
CA2816416C (en) 2010-10-31 2020-02-11 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
BR112013018688B1 (pt) 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc Método de produção de uma composição polimérica de proantocianidina
CN104487075A (zh) 2012-02-29 2015-04-01 普马特里克斯公司 可吸入干粉剂
AU2013233930A1 (en) * 2012-03-13 2014-09-25 Piramal Enterprises Limited Herbal composition for the treatment of metabolic disorders
KR101349609B1 (ko) * 2012-06-08 2014-01-09 순천향대학교 산학협력단 어류의 백신분석을 위한 indicator 및 이를 이용한 어류용 백신 분석방법
KR20150135328A (ko) 2013-04-01 2015-12-02 풀매트릭스 인코퍼레이티드 티오트로피움 건조 분말
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
CA3131609A1 (en) * 2019-03-29 2020-10-08 Evonik Operations Gmbh Treatment and prevention of infections by herpesviridae with delphinidin-3-glucoside
CN114624367B (zh) * 2020-12-14 2023-05-09 四川大学 一种采用固态氧鎓盐无溶剂加压提取竹叶黄酮的方法
US20230060934A1 (en) * 2021-08-25 2023-03-02 Michael Wayne Dockery Botanical antiviral nutritional supplement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2226185A1 (en) * 1973-04-20 1974-11-15 Vincent Yves Therapeutically active tannin fractions prepd. - from Cupressus sempervirens fruits by extracting with solvents
CA1086651A (en) * 1977-12-12 1980-09-30 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health And Welfare Canada Compositions for, and treatment of, herpes viral infections
US4335110A (en) * 1979-08-23 1982-06-15 Orewa Inc. Pharmaceutical compositions of sanguinaria galangal and zinc chloride
JPS59196884A (ja) * 1983-04-20 1984-11-08 Nippon Shinyaku Co Ltd 新規なるタンニン
JPS61205272A (ja) * 1985-03-08 1986-09-11 Tsumura Juntendo Inc 新規なタンニン
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
JPH0231074B2 (ja) * 1986-08-26 1990-07-11 Nippon Shinyaku Co Ltd Shintannin
CA2001898A1 (en) * 1988-10-31 1990-04-30 Kuo-Hsiung Lee Inhibition of human retroviruses
WO1990013304A1 (fr) * 1989-05-12 1990-11-15 Institut Des Substances Vegetales Composition a base de proanthocyanidols; leur application pharmacologique

Also Published As

Publication number Publication date
CA2093825A1 (en) 1992-04-13
SG52707A1 (en) 1998-09-28
JPH06502413A (ja) 1994-03-17
US5494661A (en) 1996-02-27
EP0553253B1 (en) 2000-07-05
AU8878091A (en) 1992-05-20
KR100207949B1 (ko) 1999-07-15
EP0553253A1 (en) 1993-08-04
JP3448052B2 (ja) 2003-09-16
US5211944A (en) 1993-05-18
CA2093825C (en) 2003-01-07
KR930702010A (ko) 1993-09-08
EP0553253A4 (en) 1993-09-15
DE69132289D1 (de) 2000-08-10
WO1992006695A1 (en) 1992-04-30
AU660631B2 (en) 1995-07-06
NZ240200A (en) 1994-04-27
ATE194288T1 (de) 2000-07-15

Similar Documents

Publication Publication Date Title
MX9101540A (es) Polimeros de proantocianidina que tienen actividad antiviral y metodos para obtener los mismos
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
BR8101233A (pt) Composicoes herbicidas, processo para o combate de ervas daninhas e emprego
BR9001023A (pt) Composicoes e tratamentos biocidas
MX174528B (es) Desintoxicacion del terreno
PT71648A (de) Vorrichtung zur sicherung von insbesondere lichtschachten oder dergleichen gegen einbruch
MX9202781A (es) Vacuna y metodo de tratamiento para virus de inmunodeficiencia humana.
ES2060918T3 (es) Derivados de ciclopropilo que poseen actividad inhibidora lipoxigenasa.
BR8702808A (pt) Processo para preparar 1,3,5-triazin-2,4,6-trionas trissubstituidas,composicoes para combate de pragas,aplicacao dos compostos mencionados,bem como processos para combate de pragas e para preparar tais composicoes
ES2058343T3 (es) Piridinas disubstituidas.
ES2036526T3 (es) Composiciones de interferon.
IT7821229A0 (it) Mezzo per la protezione di legno e oggetti di legno.
BR9100185A (pt) Composicoes fungicidas,processos para combater fungos e para a preparacao de composicoes
BR9102155A (pt) Composto herbicida,processo para controlar especies de plantas monocotiledoneas e dicotiledoneas,composicao herbicida e processo para preparar o composto
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
BR9100177A (pt) Composicoes fungicidas,processos para combater fungos e a preparacao de composicoes
ES2088458T3 (es) Fraccion antiviral de extracto acuoso de lentinus edodes.
TR21686A (tr) Fungisidler,ve oezellikle omisetleri kontrola mahsus fungisidler veya bunlarla ilgili islahat
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.
IT1178809B (it) Comosto di tetraetilammonio per l uso nel trattamento di malattie provocate da virus erpetici
BR8101934A (pt) Processo para a preparacao de n-alonil-halogenacetanilidas,composicoes herbicidas e reguladoras do crescimento,processo para o combate de ervas daninhas e para a preparacao de composicoes
ATA239886A (de) Vorrichtung zur beeinflussung des elektromagnetischen erdfeldes, insbesondere zwecks entfeuchtung von mauerwerk
IT1112692B (it) Purificatore dell'aria,specie cappa aspirante per cucine o similare
DE59002982D1 (de) Verwendung von substituierten Bis-azolyl-Derivaten zur Bekämpfung von Pilzen im Pflanzenschutz.
LV5574A3 (lv) Panemiens nevelamo augu apkarosanai